Onyx Healthcare Inc. (TPEX:6569)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
96.10
+2.20 (2.34%)
At close: Mar 6, 2026

Onyx Healthcare Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,3131,2411,4931,6001,202
Revenue Growth (YoY)
5.80%-16.85%-6.71%33.16%-10.80%
Cost of Revenue
879.27784.98936.721,128838.03
Gross Profit
434.02456.28556.14472.31363.73
Selling, General & Admin
271.23247.47258.98241.59208.96
Research & Development
112.49118.3279.3686.6779.35
Operating Expenses
381.77367.55338.02326.91289.22
Operating Income
52.2488.73218.12145.3974.51
Interest Expense
-4.68-4.36-3.68-3.56-2.63
Interest & Investment Income
2.4113.883.394.696.36
Earnings From Equity Investments
68.5167.162.8762.9450.19
Currency Exchange Gain (Loss)
-13.12-7.4219.28-6.02
Other Non Operating Income (Expenses)
3.421819.8525.4118.57
EBT Excluding Unusual Items
121.91196.47293.14254.14140.98
Gain (Loss) on Sale of Investments
-9.9511.86-12.45-0.87
Gain (Loss) on Sale of Assets
---0.25-
Other Unusual Items
--0.010.010.09-0.01
Pretax Income
121.91206.41305242.03140.11
Income Tax Expense
10.2126.2849.8338.913.6
Earnings From Continuing Operations
111.7180.13255.17203.14126.51
Minority Interest in Earnings
0.430.790.09-0.181.04
Net Income
112.13180.91255.26202.96127.55
Net Income to Common
112.13180.91255.26202.96127.55
Net Income Growth
-38.02%-29.13%25.77%59.12%-23.66%
Shares Outstanding (Basic)
3939383735
Shares Outstanding (Diluted)
3939393835
Shares Change (YoY)
0.35%0.61%2.85%7.68%-0.14%
EPS (Basic)
2.884.696.665.433.67
EPS (Diluted)
2.874.656.605.393.65
EPS Growth
-38.28%-29.54%22.41%47.62%-23.50%
Free Cash Flow
147.49117.53282.91149.84-277.64
Free Cash Flow Per Share
3.773.027.313.98-7.95
Dividend Per Share
-4.0004.3484.3483.479
Dividend Growth
--8.01%-25.00%-20.00%
Gross Margin
33.05%36.76%37.25%29.51%30.27%
Operating Margin
3.98%7.15%14.61%9.09%6.20%
Profit Margin
8.54%14.57%17.10%12.68%10.61%
Free Cash Flow Margin
11.23%9.47%18.95%9.36%-23.10%
EBITDA
74.05105.12235.93163.6390.84
EBITDA Margin
5.64%8.47%15.80%10.22%7.56%
D&A For EBITDA
21.8116.417.8118.2416.33
EBIT
52.2488.73218.12145.3974.51
EBIT Margin
3.98%7.15%14.61%9.09%6.20%
Effective Tax Rate
8.37%12.73%16.34%16.07%9.71%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.